A patient diagnosed with ovarian cancer in her 4th decade and a strong family history of breast and ovarian cancer had previously tested negative for deleterious BRCA1 and BRCA2 mutations by another commercial lab. This evidence concerns the gene BRCA1 and ovarian carcinoma.